Emerging properties of cannabinoid medicines in management of multiple sclerosis

被引：60
|
作者：
Pryce, G [1 ]
Baker, D [1 ]
机构：
[1] UCL, Inst Neurol, Dept Neuroinflammat, London WC1N 1PJ, England
来源：
TRENDS IN NEUROSCIENCES | 2005年 / 28卷 / 05期
关键词：
D O I：
10.1016/j.tins.2005.03.006
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Use of cannabis as a medicine for numerous conditions has a well-documented history stretching back thousands of years. With the identification of an endogenous system of receptors and ligands in recent years, abundant experimental data have reinforced the anecdotal claims of people who perceive medicinal benefit from the currently illegal consumption of cannabis. This, combined with data from recent clinical trials, points to the prospect of cannabis as a medication in the treatment of multiple sclerosis and numerous other medical conditions.
引用
收藏
页码：272 / 276
页数：5
相关论文
共 50 条
  • [1] Cannabinoid-Based Medicines and Multiple Sclerosis
    Manera, Clementina
    Bertini, Simone
    CANNABINOIDS AND NEUROPSYCHIATRIC DISORDERS, 2021, 1264 : 111 - 129
  • [2] Emerging Therapies for the Management of Multiple Sclerosis
    Namaka, Michael
    Leong, Christine
    Prout, Michael
    Le Dorze, Josee-Anne
    Limerick, Mike
    Frost, Emma
    Esfahani, Farid
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 307 - 319
  • [3] Emerging strategies for exploiting cannabinoid receptor agonists as medicines
    Pertwee, Roger G.
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 156 (03) : 397 - 411
  • [4] New cannabinoid for multiple sclerosis
    Whelan, J
    DRUG DISCOVERY TODAY, 2002, 7 (14) : 745 - 746
  • [5] Cannabinoid receptor expression in multiple sclerosis
    Hilton, DA
    Mukonoweshuro, P
    Zajicek, J
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2005, 31 (02) : 240 - 240
  • [6] Cannabinoid receptors expression in multiple sclerosis
    Zhang, H.
    Hanemann, O.
    Widmer, M.
    Hosking, R.
    Chadborn, N.
    Zajicek, J.
    Hilton, D. A.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2009, 35 : 17 - 17
  • [7] First cannabinoid drug for multiple sclerosis
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (07) : 369 - 369
  • [8] Essential medicines for patients with multiple sclerosis
    不详
    LANCET NEUROLOGY, 2019, 18 (12): : 1067 - 1067
  • [9] The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis
    Centonze, Diego
    Rossi, Silvia
    Finazzi-Agro, Alessandro
    Bernardi, Giorgio
    Maccarrone, Mauro
    NEUROINFLAMMATION IN NEURONAL DEATH AND REPAIR, 2007, 82 : 171 - 186
  • [10] Cannabinoid influence on cytokine profile in multiple sclerosis
    Katona, S
    Kaminski, E
    Sanders, H
    Zajicek, J
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 140 (03): : 580 - 585
12345